Table 1.
List of all nucleosomal modifying drugs screened for modulating hMSC differentiation.
| List of drugs screened | ||
|---|---|---|
| (1) AGK2 | (29) Delphinidin chloride | (57) Oxamflatin |
| (2) CAY10433 | (30) ITF 2357 | (58) 2′,3′,5′-triacetyl-5-Azacytidine |
| (3) M 344 | (31) 3-Deazaneplanocin A | (59) Salermide |
| (4) HNHA | (32) Suramin (sodium salt) | (60) Mirin |
| (5) Octyl-α-ketoglutarate | (33) PFI-1 | (61) UNC1999 |
| (6) Cl-Amidine (trifluoroacetate salt) | (34) 5-Azacytidine | (62) Pimelic Diphenylamide 106 |
| (7) CAY10669 | (35) Chaetocin | (63) MS-275 |
| (8) HC Toxin | (36) Decitabine | (64) RG-108 |
| (9) JGB1741 | (37) (+)-JQ1 | (65) S-Adenosylhomocysteine |
| (10) Garcinol | (38) (—)-JQ1 | (66) UNC0224 |
| (11) MI-2 (hydrochloride) | (39) BSI-201 | (67) Chidamide |
| (12) Sinefungin | (40) IOX1 | (68) Pyroxamide |
| (13) Suberohydroxamic Acid | (41) MI-nc (hydrochloride) | (69) N-Oxalylglycine |
| (14) Valproic Acid | (42) Gemcitabine | (70) WDR5-0103 |
| (15) Resveratol | (43) Lomeguatrib | (71) AMI-1 (sodium salt) |
| (16) 3-amino Benzamide | (44) Daminozide | (72) UNC1215 |
| (17) 4-iodo-SAHA | (45) GSK-J1 (sodium salt) | (73) GSK 343 |
| (18) C646 | (46) GSKJ2 (sodium salt) | (74) Bromosporine |
| (19) Ellagic Acid | (47) GSK-J4 (hydrochloride) | (75) SIRT1/2 Inhibitor IV |
| 20) Scriptaid | 48) GSK-J5 (hydrochloride) | 76) I-CBP112 (hydrochloride) |
| (21) UNC0321 (trifluoroacetate salt) | (49) Tenovin-1 | (77) PFI-3 |
| (22) (-)-Neplanocin A | (50) Tenovin-6 | (78) 2,4-DPD |
| (23) F-Amidine (trifluoroacetate salt) | (51) BIX01294 (hydrochloride hydrate) | (79) DMOG |
| (24) UNC0638 | (52) Anacardic Acid | (80) Trichostatin A |
| (25) Phthalazinone pyrazole | (53) CAY10603 | (81) CAY10398 |
| (26) Isoliquiritigenin | (54) Splitomicin | (82) RSC-133 |
| (27) CCG-100602 | (55) CBHA | (83) Piceatannol |
| (28) Zebularine | (56) Oxamflatin | (84) CAY10591 |